St. Jude Medical: Competitor’s Recall Clouds ICD Market Predictions
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical believes it is well positioned to continue increasing its share of the implantable cardioverter defibrillator market in 2008, even though it is too soon to predict the precise impact of competitor Medtronic's Sprint Fidelis ICD lead recall